[HTML][HTML] Summary of Safety and Efficacy of COVID Vaccination in patients with multiple sclerosis
E Pernicová, P Macounová, M Krsek, R Maďar - European Neurology, 2023 - karger.com
Background: The SARS-CoV-2 pandemic represents one of the most challenging issues that
have recently influenced everyday life in countries all over the world. Understanding the risk …
have recently influenced everyday life in countries all over the world. Understanding the risk …
SARS-CoV-2, long COVID, prion disease and neurodegeneration
Y Zhao, VR Jaber, WJ Lukiw - Frontiers in Neuroscience, 2022 - frontiersin.org
On the last day of the year 2019 a novel Betacoronavirus (2019-nCov), now known as
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and causing the highly …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and causing the highly …
Single‐cell multi‐omics analysis of COVID‐19 patients with pre‐existing autoimmune diseases shows aberrant immune responses to infection
A Barmada, LF Handfield… - European Journal of …, 2024 - Wiley Online Library
In COVID‐19, hyperinflammatory and dysregulated immune responses contribute to
severity. Patients with pre‐existing autoimmune conditions can therefore be at increased risk …
severity. Patients with pre‐existing autoimmune conditions can therefore be at increased risk …
[HTML][HTML] Safety and effectiveness of the booster dose of mRNA COVID-19 vaccines in people with multiple sclerosis: A monocentric experience
A Bertozzi, A Mariottini, L Marchi, M Di Cristinzi… - Multiple Sclerosis and …, 2023 - Elsevier
Background Long-term data on the effectiveness and safety of the booster dose of anti-
SARS-CoV-2 vaccines in people affected by multiple sclerosis (pwMS) are lacking, hence a …
SARS-CoV-2 vaccines in people affected by multiple sclerosis (pwMS) are lacking, hence a …
Comparing the consequences of COVID-19 vaccination between central nervous system (CNS) demyelinating diseases and other neurological disorders
Background Vaccination constitutes a crucial preventive measure against COVID-19
infection. Concerns have been raised regarding the efficacy of vaccines in multiple sclerosis …
infection. Concerns have been raised regarding the efficacy of vaccines in multiple sclerosis …
Animal model of multiple sclerosis: Experimental autoimmune encephalomyelitis
A Muñoz-Jurado, BM Escribano… - Methods in cell …, 2024 - pubmed.ncbi.nlm.nih.gov
Multiple sclerosis (MS) is a very complex and heterogeneous disease, with an unknown
etiology and which, currently, remains incurable. For this reason, animal models are crucial …
etiology and which, currently, remains incurable. For this reason, animal models are crucial …
[图书][B] Multiple sclerosis, viruses, and B cell depleting therapy: a meeting at the immune system
K Asplund Högelin - 2024 - openarchive.ki.se
Multiple sclerosis (MS) is a highly heterogeneous disease with a complex and undiscovered
etiology. Two of the strongest established risk factors for developing MS are carriage of the …
etiology. Two of the strongest established risk factors for developing MS are carriage of the …